U.S. Medical Equipment Stock News

NYSE:TYL
NYSE:TYLSoftware

Tyler Technologies (TYL) Stock Could Be 37% Undervalued On Cash Flow

Tyler Technologies has seen a sharp reset in its share price over the past year, and that slide puts fresh focus on whether the cash the business can generate really supports where the stock now trades. For investors watching a software specialist built around government customers, the key issue is how its cash flows stack up against today's market value. Over the past 12 months the share price has fallen 35.6%, which puts a lot of previous optimism about Tyler Technologies into question and...
NYSE:DT
NYSE:DTSoftware

How Sopra Steria Partnership At Dynatrace Stock Has Changed Its Investment Story

Sopra Steria recently announced a dedicated observability and AIOps practice built around the Dynatrace platform to serve large European enterprises in sectors such as banking, insurance, telecoms, retail and government. The partnership embeds Dynatrace deeply into Sopra Steria’s managed services, turning its AI engine into part of day to day incident prevention rather than just post mortem analysis. This article examines how Dynatrace’s investment narrative is affected by Sopra Steria’s new...
NYSE:MLM
NYSE:MLMBasic Materials

Martin Marietta Materials (MLM) Stock Looks Undervalued As Shares Sit Below Earlier Highs

Martin Marietta Materials has pulled back sharply this year after a strong multi year run, which puts fresh attention on whether the current share price lines up with the cash the business can generate. With the stock now well below its earlier highs, the key issue is how that market reset lines up against its underlying cash flows. Over the past 5 years, the stock has gained about 43.2%, so a lot of long term value creation is already reflected in the price and invites a closer look at what...
NYSE:COP
NYSE:COPOil and Gas

How Falling Oil Prices Will Impact ConocoPhillips Stock Investors

ConocoPhillips recently saw its shares fall alongside other oil and gas producers after crude prices weakened, as supply concerns eased and U.S. inventory data pointed to softer market tightness. The pullback arrived even as earnings expectations for ConocoPhillips moved higher, with analysts projecting a 60.25% EPS uplift and 11.47% revenue expansion versus the same quarter last year. This development raises questions about how ConocoPhillips' investment narrative relates to softer crude...
NasdaqGS:QCOM
NasdaqGS:QCOMSemiconductor

Qualcomm (QCOM) Stock May Be Fully Priced After AI Data Center Deal

QUALCOMM has ridden a strong multi‑year run in its share price, and a fresh wave of AI related headlines has pushed the story back into focus, so the key issue now is whether that price really lines up with the cash the business is expected to generate. With a Discounted Cash Flow (DCF) framework available, the question is how the recent momentum and new agreements filter through to that intrinsic value estimate. Over the past 3 years, QUALCOMM has delivered a total return of 86.3%, which...
NasdaqGM:USAR
NasdaqGM:USARMetals and Mining

USA Rare Earth (USAR) Stock Looks Like A Bargain On Book Value

USA Rare Earth has delivered a 52.9% gain over the past three years, even as shorter term moves have been more mixed. That puts a spotlight on whether the current share price sits comfortably against what its balance sheet is actually worth on paper. A 52.9% return over three years gives early buyers a healthy cushion and raises the question of how much of that move is supported by the company’s book value per share. The recent partnership with Pasqal and Riven Systems to develop advanced...
NYSE:JNJ
NYSE:JNJPharmaceuticals

Johnson & Johnson (JNJ) Advances Sjögren's Therapies With New Biomarker Trial Data

Johnson & Johnson (NYSE: JNJ) reported new biomarker findings tied to its targeted therapies for Sjögren's syndrome in ongoing trials. The pharmaceutical segment highlighted disease-modifying candidates in clinical development for immune-mediated conditions beyond oncology headlines. Exploratory biomarker data are being used to refine patient selection for Sjögren's syndrome studies, aiming for more tailored treatment approaches. Johnson & Johnson's new Sjögren's syndrome biomarker and...
NYSE:FNF
NYSE:FNFInsurance

Is Fidelity National Financial (FNF) Undervalued After LoanCare Prepared For The VA Partial Claim Program?

Fidelity National Financial (FNF) has moved back into focus after subsidiary LoanCare finished preparations to launch the Department of Veterans Affairs Partial Claim Program, positioning the group within a key support channel for veteran homeowners. Recent trading has been softer for Fidelity National Financial, with the share price down 11.14% over the past 30 days and 20.65% year to date. However, the 5‑year total shareholder return of 23.93% points to a much stronger longer term...
NasdaqGS:TSLA
NasdaqGS:TSLAAuto

Latest News In Electric Vehicles - Subaru Partners With onsemi To Advance Power Architecture Integration

Subaru has embarked on a strategic collaboration with onsemi to evaluate its Embedded Power Platform (EPP), marking a significant step towards integrating next-generation power architectures in future electric vehicles. This partnership aims to explore how a more integrated power system design can enhance vehicle performance, efficiency, and design flexibility, crucial elements as automakers expand their electrified vehicle offerings. By gaining early access to engineering samples and...
NasdaqGS:AMAT
NasdaqGS:AMATSemiconductor

Applied Materials (AMAT) Will Invest $5 Billion In An India Semiconductor Hub

Applied Materials (NasdaqGS:AMAT) plans to invest US$5b to build a 140 acre semiconductor R&D hub in India. The project targets a tenfold expansion of Applied Materials' India based supply chain capacity by 2035. Management plans to use the new Indian hub to support semiconductor research partnerships, supplier development and local job creation. This US$5b India R&D hub plan is important, but investors should weigh it alongside other Applied Materials risks and fundamentals. Check out 2...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Axsome Therapeutics (AXSM) Unveils New Depression And Alzheimer’s Agitation Data At Psych Congress 2026

Axsome Therapeutics (NasdaqGM: AXSM) presented new clinical data in major depressive disorder and Alzheimer’s disease agitation at Psych Congress 2026. The company also shared additional scientific findings from across its psychiatry and neurology pipeline at the same meeting. Management highlighted how the new evidence base could inform future clinical practice and potential regulatory discussions for its programs. The fresh data in major depressive disorder and Alzheimer’s disease...
NYSE:FLS
NYSE:FLSMachinery

Flowserve (FLS) Names Its Next CFO, Is The Stock Still A Bargain?

Flowserve (FLS) just announced a planned handover in its finance leadership, with current CFO Amy B. Schwetz set to depart and long-time finance executive Brian Ezzell scheduled to step into the role on October 1, 2026. Flowserve’s leadership reshuffle comes at a time when the share price has pulled back, with a 30 day share price return of 6.41% down and a 90 day return of 9.74% down. However, the 1 year total shareholder return of 29.45% and 5 year total shareholder return of 128.76%...
NYSE:CFR
NYSE:CFRBanks

Is Cullen/Frost Bankers (CFR) Fairly Valued After Its Recent Pullback?

Cullen/Frost Bankers (CFR) is back in focus after commentary highlighting its unexciting sales trends, lagging earnings per share growth compared with banking peers, and a forward price to book multiple of 2.2x. Recent trading has been choppy for Cullen/Frost Bankers, with the share price slipping 4.6% over the past month after a 9.6% gain across the last 90 days and a 24.55% year to date share price return. The 1 year total shareholder return of 27.65% and 3 year total shareholder return of...
NYSE:PPL
NYSE:PPLElectric Utilities

Will Funding Pressure Change PPL's (PPL) Narrative

PPL has faced company specific financial pressures, with higher operating costs and large capital investment needs weighing on its recent performance. The combination of these cost and funding demands, along with higher Treasury yields, has sharpened investor focus on PPL's balance between growth spending and financing risk. We will now look at how PPL's investment narrative is shaped by these rising costs and the capital intensive conditions in the utility sector. Compare how PPL's funding...
NasdaqGS:SPCX
NasdaqGS:SPCXTelecom

Why Is SpaceX (SPCX) Handing Investors $8.5 Billion In Shares?

Space Exploration Technologies (NasdaqGS: SPCX) shareholder Valor Equity Partners has distributed US$8.5b of SpaceX shares to its investors via an in-kind transfer. The in-kind distribution shifts SpaceX ownership from Valor's funds directly to limited partners rather than relying on an open market sale. Valor remains a multi billion dollar holder in SpaceX after the transaction, keeping a large institutional position in the private company. The in kind distribution of US$8.5b in SpaceX...
NYSE:LTH
NYSE:LTHHospitality

What Is Life Time Group Holdings (LTH) Up To With Its New Private Community?

Life Time Group Holdings (NYSE:LTH) introduced Life Time Social, a private membership community focused on curated wellness and social experiences. The company also launched a Guaranteed Interview Program with ISSA that offers certified personal trainers a direct path to employment opportunities at Life Time locations. Life Time Social is designed to extend the brand beyond traditional athletic clubs into lifestyle, networking, and community programming for members. The launch of Life Time...
NYSE:RBLX
NYSE:RBLXEntertainment

Roblox (RBLX) Stock Could Be 36% Undervalued As Creator Tools Expand

Roblox has seen sharp swings in recent years, and with the share price last closing at US$47.50, the central question for investors is whether that tag is supported by the cash the business can generate over time. Over the past 3 years, Roblox has delivered a 87.7% return, which raises the stakes on whether its current valuation can be explained by underlying cash flows rather than sentiment alone. Fresh moves like the Roblox Everywhere push and faster creator payouts through Roblox Wallet...
NYSE:BFS
NYSE:BFSRetail REITs

Saul Centers (BFS) Holds Its Dividend, Is The Valuation Case Still Compelling?

Dividend decisions in focus Saul Centers (BFS) has affirmed a quarterly common dividend of $0.59 per share, with payment set for October 30, 2026. This keeps the payout level unchanged versus both the prior quarter and last year’s comparable period. Saul Centers shares trade at $30.31, with the 30-day share price return down 10.88% and the 90-day share price return down 15.88%. The 1-year total shareholder return of 0.62% suggests recent weakness has come after a relatively flat longer...
NYSE:BW
NYSE:BWElectrical

Babcock & Wilcox Enterprises (BW) Could Be 68% Below Fair Value Following $130 Million Project Win

Babcock & Wilcox Enterprises (BW) drew fresh attention after announcing a limited notice to proceed on an approximately US$130 million air quality control project for a U.S. coal-fired power plant. The new contract lands after a choppy run for Babcock & Wilcox Enterprises, with the share price up 7.81% over the last day and 2.09% over the past week, yet down 19.91% over 30 days and 57.88% over 90 days. Even with that recent loss of momentum in the share price, long term investors have seen a...
NYSE:WK
NYSE:WKSoftware

Could Agent Studio Alter The Investment Case For Workiva (WK)?

Workiva used its Amplify 2026 conference to launch Agent Studio and several AI-driven solutions that automate complex regulatory reporting, internal audit, and GRC workflows without code. The push into AI agents for tasks like BEA and US Census surveys signals a bid to widen Workiva’s addressable compliance workload inside a single platform. We will now see how Workiva's new Agent Studio capability could reshape the company’s broader investment narrative and operating profile. Scan beyond...